Recent studies demonstrate the promise of RMP1-14, a newly developed anti-mouse PD-1 reagent , for enhancing malignant treatment. Unlike existing approaches, RMP1-14 exhibits superior binding to murine https://rishijdlm299558.wikicorrespondence.com/user